JP2024539721A5 - - Google Patents
Info
- Publication number
- JP2024539721A5 JP2024539721A5 JP2024526617A JP2024526617A JP2024539721A5 JP 2024539721 A5 JP2024539721 A5 JP 2024539721A5 JP 2024526617 A JP2024526617 A JP 2024526617A JP 2024526617 A JP2024526617 A JP 2024526617A JP 2024539721 A5 JP2024539721 A5 JP 2024539721A5
- Authority
- JP
- Japan
- Prior art keywords
- ppm
- less
- compound
- item
- fluoroaniline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275255P | 2021-11-03 | 2021-11-03 | |
| US63/275,255 | 2021-11-03 | ||
| PCT/US2022/048770 WO2023081253A1 (en) | 2021-11-03 | 2022-11-03 | Compounds for the treatment of kinase-dependent disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539721A JP2024539721A (ja) | 2024-10-29 |
| JP2024539721A5 true JP2024539721A5 (https=) | 2025-11-11 |
Family
ID=84462825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526617A Pending JP2024539721A (ja) | 2021-11-03 | 2022-11-03 | キナーゼ依存性障害の治療のための化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250051284A1 (https=) |
| EP (1) | EP4426678A1 (https=) |
| JP (1) | JP2024539721A (https=) |
| CN (1) | CN118176182A (https=) |
| AR (1) | AR127561A1 (https=) |
| AU (1) | AU2022383160A1 (https=) |
| CA (1) | CA3235602A1 (https=) |
| TW (1) | TW202334090A (https=) |
| WO (1) | WO2023081253A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117402114A (zh) * | 2018-01-26 | 2024-01-16 | 埃克塞里艾克西斯公司 | 用于治疗激酶依赖性病症的化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117402114A (zh) * | 2018-01-26 | 2024-01-16 | 埃克塞里艾克西斯公司 | 用于治疗激酶依赖性病症的化合物 |
| KR102828472B1 (ko) * | 2018-12-13 | 2025-07-03 | 엑셀리시스, 인코포레이티드 | 키나아제 억제제의 결정질 형태 및 염 형태 |
| MX2021014773A (es) * | 2019-06-03 | 2022-01-18 | Exelixis Inc | Formas de sales cristalinas de un inhibidor de cinasas. |
| CN115461328B (zh) * | 2020-04-30 | 2025-11-07 | 埃克塞里艾克西斯公司 | 用于制备激酶抑制剂的方法 |
| JP2023548855A (ja) * | 2020-11-05 | 2023-11-21 | エグゼリクシス， インコーポレイテッド | キナーゼ阻害剤の医薬組成物 |
-
2022
- 2022-11-02 TW TW111141900A patent/TW202334090A/zh unknown
- 2022-11-02 AR ARP220103011A patent/AR127561A1/es unknown
- 2022-11-03 US US18/706,757 patent/US20250051284A1/en active Pending
- 2022-11-03 CN CN202280073218.2A patent/CN118176182A/zh active Pending
- 2022-11-03 CA CA3235602A patent/CA3235602A1/en active Pending
- 2022-11-03 AU AU2022383160A patent/AU2022383160A1/en active Pending
- 2022-11-03 EP EP22821747.7A patent/EP4426678A1/en active Pending
- 2022-11-03 JP JP2024526617A patent/JP2024539721A/ja active Pending
- 2022-11-03 WO PCT/US2022/048770 patent/WO2023081253A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6776330B2 (ja) | 抗菌化合物 | |
| TW199861B (https=) | ||
| AU2008253696B2 (en) | Formoterol tartrate process and polymorph | |
| Felix-Sonda et al. | Nitazoxanide cocrystals in combination with succinic, glutaric, and 2, 5-dihydroxybenzoic acid | |
| JP2024539721A5 (https=) | ||
| EP4218755A1 (en) | Method for preparing crystalline particles of 1-(3-cyano-1-isopropyl-indole-5-yl)pyrazole-4-carboxylic acid, and pharmaceutical composition comprising same | |
| EP1289364B1 (en) | Stable gabapentin containing more than 2o ppm of chlorine ion | |
| AU2001266992B8 (en) | Stable gabapentin having pH within a controlled range | |
| WO2014167428A2 (en) | Amorphous 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-n-methylbenzamide | |
| AU2001266992A1 (en) | Stable gabapentin having pH within a controlled range | |
| KR970010744A (ko) | N-메틸-n-[(1s)-1-페닐-2-((3s)-3-하이드록시피롤리딘-1-일)에틸]-2,2-디페닐아세트아미드 | |
| WO2015071831A1 (en) | An improved process for minimising the formation of dehalogenated byproducts | |
| EP2563355B1 (en) | Process for the production of ralfinamide methanesulfonate salts or their R-enantiomers | |
| CA2530310A1 (en) | Substituted diketopiperazines and their use as oxytocin antagonists | |
| JP4891478B2 (ja) | シクロホスファミド被覆錠剤 | |
| JP2017538720A (ja) | 医薬調製物用の（ｓ）−ｎ−（３−（６−イソプロポキシピリジン−３−イル）−１ｈ−インダゾール−５−イル）−１−（２−（４−（４−（１−メチル−１ｈ−１，２，４−トリアゾール−３−イル）フェニル）−３，６−ジヒドロピリジン−１（２ｈ）−イル）−２−オキソエチル）−３−（メチルチオ）ピロリジン−３−カルボキサミド組成物 | |
| RU2003126176A (ru) | Кислотно-аддитивные соли тербинафина и яблочной кислоты | |
| CN1880294B (zh) | 右酮洛芬氨丁三醇的多晶型、其制备方法和包含它的组合物 | |
| WO2005084679A1 (ja) | ベンズアミジン誘導体含有組成物及びベンズアミジン誘導体の安定化方法 | |
| JP2022007461A (ja) | トルバプタン含有口腔内崩壊錠 | |
| CN1469863A (zh) | 1-[6-氯-5-(三氟甲基)-2-吡啶基]哌嗪盐酸盐的晶形 | |
| RU2580837C1 (ru) | Кристаллогидрат 4-аминопиридина, способ его получения, фармацевтическая композиция и способ лечения и/или профилактики на её основе | |
| JP2004182695A (ja) | イソロイシン誘導体及び増粘ゲル化剤 | |
| CA2376025A1 (fr) | Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme antifongiques | |
| TH48596A (th) | เอทิล (2s)-2-(แนฟทาลีน-1-ซัลโฟนิลอะมิโน)-3-(4-(2-(1,4,5,6-เตตราไฮโดรไพริมิดิน-2-อิลคาร์บาโมอิล)เอทิล)เบนโซอิลอะมิโน)โพรพิโอเนตเฮมิฟูมาเรต, กระบวนการ และสารมัธยันตร์สำหรับการเตรียมสารดังกล่าว และการใช้สารดังกล่าวเป็นสารทางเภสัชกรรม |